![Dina DiCenso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Prior to joining Epoch, Dr. DiCenso was an associate at Finnerty Economic Consulting where she specialized in statistical analysis of financial and economic data.
She is currently an Adjunct Professor at Fordham University where she is teaching managerial and macro-economics classes.
Dr. DiCenso was an economic and policy research analyst at Pfizer, and held various positions at Zurich Scudder Investments and Liberty Mutual Funds.
Dr. DiCenso earned a Ph.D.
in Economics from Fordham University, an MSF from Northeastern University, and a BA in Philosophy and Classics from the University of Arizona.
Eerdere bekende functies van Dina DiCenso
| Bedrijven | Functie | Einde |
|---|---|---|
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Corporate Officer/Principal | 30-07-2004 |
Zurich Scudder Investments, Inc.
 Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services | Corporate Officer/Principal | 30-04-2001 |
Partners First
 Partners First Finance/Rental/LeasingFinance Provides credit cards and services | Corporate Officer/Principal | 31-12-1999 |
Epoch Investment Partners, Inc.
 Epoch Investment Partners, Inc. Investment ManagersFinance TD Epoch’s investment approach for equity strategies is based on bottom-up, fundamental research, seeking companies that can grow free cash flow and allocate it intelligently for the benefit of shareholders or have superior earnings growth. Their approach to portfolio construction for fixed income strategies is disciplined and focuses on sector allocation, yield curve analysis and credit quality. | Analyst-Equity | - |
Opleiding van Dina DiCenso
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Zurich Scudder Investments, Inc.
Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services | Finance |
Partners First
Partners First Finance/Rental/LeasingFinance Provides credit cards and services | Finance |
Epoch Investment Partners, Inc.
Epoch Investment Partners, Inc. Investment ManagersFinance TD Epoch’s investment approach for equity strategies is based on bottom-up, fundamental research, seeking companies that can grow free cash flow and allocate it intelligently for the benefit of shareholders or have superior earnings growth. Their approach to portfolio construction for fixed income strategies is disciplined and focuses on sector allocation, yield curve analysis and credit quality. | Finance |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Venture Investments LLC
Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Finance |
Kies MarketScreener 
